Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

What's ahead for Apple after its rough start to 2024?

Year to date, Apple Inc. shares are down more than 10 per cent In April, Apple lost its top spot on the global smartphone list, replaced by Samsung “There are still current estimates suggesting that Apple can return 50 per cent this year&CloseCurlyDouble...

Buzz on the Bullboards: Finding Diamonds in the Rough

While the markets were rocked at the end of January by the Wuhan coronavirus, the beginning of February has seen a return to the non-stop climb that began in last fall. Once we break things down by sector, however, the picture becomes murkier. The cannabis sector continues...

Hemostemix Founder: A Man with a Compassionate Heart

The Canadian stem cell company Hemostemix Inc. ( TSX-V: HEM , OTC: HMTXF ) was founded by a man who truly had a compassionate heart and a clear intent to establish a breakthrough in heart disease using the same technology that saved his life. Roger Bergersen, who train...

Revolutionizing vascular grafting with a durable solution

Our next guest is a multi-technology biomedical company, focused on the development and commercialization of medical technologies. Marizyme Inc. (OTCQB:MRZM) has had its sights set on development of medical technology and products, one of which is DuraGraft. J...

Medigene, Memphasys, Qiagen - which stocks belong in the portfolio?

In times of price fluctuations, so-called 'buy on dips' strategy can be an effective method of achieving a favorable entry price for listed companies. Global trends as a framework can be decisive for a successful investment decision. For a modern society, the healthcare sector...

How Ontario’s Top Cannabis Edibles Producer is Growing During Coronavirus

First, the coronavirus pandemic brought the cannabis sector (and the markets) down. Then, cannabis bounced back, posting record sales and being labelled an essential service in most locations. How do you find the cannabis companies that will succeed during uncertain time...

Disruptive Technology Poised to Deliver Significant Advancement in Bladder Cancer Detection

Chris Temple, editor and publisher of The National Investor, explains why he recommends this small-cap as a Buy. Imagin Medical's disruptive technology is poised to deliver the most significant advancement in bladder cancer detection and removal in decades , ma...

Best Canadian Stocks

When it comes to investing in Canadian companies, bigger is not always better. Canada’s historic corporate giants – energy and material sectors, such as the forestry industry – have had a difficult time over the past few years due to macroeconomic condition...

Buzz on the Bullboards: AI stocks and energy plays getting noticed

Markets have had it rough, starting the month of August lower following one downer of a corporate earnings report after another. Wall Street has struggled since credit assessor Fitch downgraded the United States’ credit rating from gold-standard AAA to...

Buzz on the Bullboards: Summer's most talked about stocks

August has been a rough month for North American stock markets, with red days and a lot of flat trading activity. Shares of U.S. banks fell this week after several regional lenders were hit with a credit downgrade. Retailers are stuck with products that aren&CloseCurl...
1 2 3 4 5 6 7 8